Pharmacy Services Managing Director Reg Blackburn recently spoke with The Deal regarding the possible sale of Pentec Health. The private equity backed company treats hemodialysis patients and peritoneal dialysis patients and will most likely generate a lot of interest from potential buyers.
“People that are successful putting together the facilities and processes that meet FDA standards are going to be delivering products to a market that has plenty of demand with fewer providers able to do it under the guidelines.”